Juan Francisco Lopez-Caleya1, Luis Ortega-Valín2, Tania Fernández-Villa3, Miguel Delgado-Rodríguez4, Vicente Martín-Sánchez3,5, Antonio José Molina6. 1. Servicio de Medicina Interna, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain. 2. Department of Pharmacy, Complejo Asistencial Universitario de León, León, Spain. 3. Faculty of Health Sciences, The Research Group in Gene-Environment and Health Interactions (GIIGAS) / Institut of Biomedicine (IBIOMED), University of Leon, Campus de Vegazana s/n, 24071, León, Spain. 4. Division of Preventive Medicine, University of Jaén, Jaén, Spain. 5. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029, Madrid, Spain. 6. Faculty of Health Sciences, The Research Group in Gene-Environment and Health Interactions (GIIGAS) / Institut of Biomedicine (IBIOMED), University of Leon, Campus de Vegazana s/n, 24071, León, Spain. ajmolt@unileon.es.
Abstract
PURPOSE: The aim of this study is to analyze the current evidence about the relationships between calcium/vitamin D and CRC based on case-control studies according to sex, tumor location and continental region to complement the information obtained in meta-analyses of other designs. METHODS: The articles were located in three databases (PUBMED, EMBASE and SCOPUS), they should be written in English language, with a case and control design and published between 1 January 1970 and 31 October 2019. RESULTS: There were 37 selected studies, 32 for intake of calcium, that involved 24,353 CRC cases and 30,650 controls, and 23 for that of VIT D, with a total of 19,076 cases and 36.746 controls included. For dietary calcium intake, the overall OR was 0.94 (95% CI 0.92-0.97), suggesting a reducing effect with a 6% decrease in CRC risk for every 300 mg of calcium ingested daily. Regarding vitamin D intake a global OR of 0.96 (95% CI 0.93-0.98) was observed, what means a 4% decrease in the risk of CRC per 100 IU/day of vitamin D. CONCLUSION: Higher dietary intakes of calcium and vitamin D are associated to a decreased risk of CRC.
PURPOSE: The aim of this study is to analyze the current evidence about the relationships between calcium/vitamin D and CRC based on case-control studies according to sex, tumor location and continental region to complement the information obtained in meta-analyses of other designs. METHODS: The articles were located in three databases (PUBMED, EMBASE and SCOPUS), they should be written in English language, with a case and control design and published between 1 January 1970 and 31 October 2019. RESULTS: There were 37 selected studies, 32 for intake of calcium, that involved 24,353 CRC cases and 30,650 controls, and 23 for that of VIT D, with a total of 19,076 cases and 36.746 controls included. For dietary calcium intake, the overall OR was 0.94 (95% CI 0.92-0.97), suggesting a reducing effect with a 6% decrease in CRC risk for every 300 mg of calcium ingested daily. Regarding vitamin D intake a global OR of 0.96 (95% CI 0.93-0.98) was observed, what means a 4% decrease in the risk of CRC per 100 IU/day of vitamin D. CONCLUSION: Higher dietary intakes of calcium and vitamin D are associated to a decreased risk of CRC.
Authors: John A Baron; Elizabeth L Barry; Leila A Mott; Judy R Rees; Robert S Sandler; Dale C Snover; Roberd M Bostick; Anastasia Ivanova; Bernard F Cole; Dennis J Ahnen; Gerald J Beck; Robert S Bresalier; Carol A Burke; Timothy R Church; Marcia Cruz-Correa; Jane C Figueiredo; Michael Goodman; Adam S Kim; Douglas J Robertson; Richard Rothstein; Aasma Shaukat; March E Seabrook; Robert W Summers Journal: N Engl J Med Date: 2015-10-15 Impact factor: 91.245
Authors: S J Winawer; J St John; J Bond; J D Hardcastle; O Kronborg; B Flehinger; D Schottenfeld; N N Blinov Journal: Bull World Health Organ Date: 1990 Impact factor: 9.408
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Michal Mego; Barbora Vlkova; Gabriel Minarik; Zuzana Cierna; Marian Karaba; Juraj Benca; Tatiana Sedlackova; Dana Cholujova; Paulina Gronesova; Katarina Kalavska; Daniel Pindak; Jozef Mardiak; Peter Celec Journal: Front Oncol Date: 2022-09-07 Impact factor: 5.738